DeepMed Research

Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Phase 1

Recruiting

Conditions: Anal Fistula

Interventions: Drug: E-CEL UVEC

First Posted Date: 2019-12-09

Last Posted Date: 2025-04-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 39

Registration Number: NCT04190862

Locations: 🇺🇸
Weill Cornell Medical College - NewYork-Presbyterian Hospital, New York, New York, United States

Giving Information Systematically and Transparently in Lung and GI Cancer Phase 2

Not Applicable

Completed

Conditions: Critical Illness
Communication
Oncology

Interventions: Behavioral: Usual Care Arm
Behavioral: Oncolo-GIST

First Posted Date: 2019-11-27

Last Posted Date: 2023-04-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 37

Registration Number: NCT04179305

Locations: 🇺🇸
Weill Cornell Medical Center, New York, New York, United States

Prospective Randomized Study of Accelerated Radiation Therapy (PRART)

Phase 3

Recruiting

Conditions: Breast Cancer

Interventions: Radiation: Radiation therapy - 3 weeks
Radiation: Radiation therapy - 2 weeks

First Posted Date: 2019-11-22

Last Posted Date: 2024-07-26

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 400

Registration Number: NCT04175210

Locations: 🇺🇸
New York Presbyterian Hospital at Lower Manhattan Cancer Center, New York, New York, United States
🇺🇸
New York Presbyterian Hospital - Queens, New York, New York, United States
🇺🇸
Brooklyn Methodist Hospital - NewYork Presbyterian, New York, New York, United States

Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy

Recruiting

Conditions: MRI Scans

Interventions: Radiation: Quantitative Susceptibility Mapping (QSM) Magnetic Resonance Imaging (MRI)
Radiation: R2* Magnetic Resonance Imaging (MRI)

First Posted Date: 2019-11-21

Last Posted Date: 2024-10-26

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 42

Registration Number: NCT04171635

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States

Radiofrequency Ablation of Atrial Fibrillation Under Apnea

Not Applicable

Active, not recruiting

Conditions: Atrial Fibrillation

Interventions: Other: Periods of Apnea
Other: Control Arm - No Periods of Apnea

First Posted Date: 2019-11-20

Last Posted Date: 2024-08-19

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 128

Registration Number: NCT04170894

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
North Shore Hospital, Manhasset, New York, United States
🇺🇸
Southside Hospital, Bay Shore, New York, United States

and more 3 locations

Pilot Study: The Effects of Medical Music on Anxiety in Patients With ILD

Not Applicable

Completed

Conditions: Interstitial Lung Disease

Interventions: Other: Medical Music

First Posted Date: 2019-11-12

Last Posted Date: 2020-01-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 10

Registration Number: NCT04159584

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Giving Information Systematically and Transparently in Lung and GI Cancer Phase 1

Completed

Conditions: Critical Illness
Oncology
Communication

Interventions: Behavioral: Oncolo-GIST

First Posted Date: 2019-11-12

Last Posted Date: 2023-04-21

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT04158908

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Lavender Aromatherapy Spine Procedure Study

Not Applicable

Completed

Conditions: Spine Injuries and Disorders
Pain, Back

Interventions: Other: Unactivated Lavender Elequil aromatabs® (#372)
Other: Activated Lavender Elequil aromatabs® (#372)

First Posted Date: 2019-11-07

Last Posted Date: 2021-02-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 109

Registration Number: NCT04156009

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy

Phase 2

Terminated

Conditions: Chronic Lymphocytic Leukemia
CLL Progression
CLL/SLL

Interventions: Drug: Umbralisib
Drug: Ublituximab

First Posted Date: 2019-11-04

Last Posted Date: 2023-06-15

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1

Registration Number: NCT04149821

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Not Applicable

Recruiting

Conditions: Coronary Artery Disease
Heart Diseases
Coronary Artery Bypass Grafting

Interventions: Procedure: Multiple arterial grafting
Procedure: Single arterial graft

First Posted Date: 2019-10-11

Last Posted Date: 2025-04-06

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 2000

Registration Number: NCT04124120

Locations: 🇨🇦
London Health Sciences, London, Ontario, Canada
🇲🇰
Acibadem-Sistina Hospital, Skopje, North Macedonia
🇨🇦
Fraser Clinical Trials, New Westminster, Canada

and more 138 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy